Johnson & Johnson stock rises Tuesday, still underperforms market
Shares of Johnson & Johnson JNJ inched 0.40% higher to $145.85 Tuesday, on what proved to be an all-around positive trading ...
Innovating With Purpose: Johnson & Johnson’s Mission To Develop Targeted Treatments For Autoantibody Diseases
By Charles Buchanan For people living with autoimmune diseases, their condition can cast a constant shadow over nearly every ...